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27
The hypervariable region-1 (HVR1) (amino acids (aa) 384-410) on the E2 glycoprotein of The concept of interfering antibodies is controversial but remains a possible mechanism that 93 contributes to the development of persistent HCV infection in infected subjects (17, 42, 49, 50 HC84.20, HC84.20, HC33.1, HC33.4, HC33.8 115 and HC33.29 against HCV E2 glycoprotein were produced as described (13, 17, (22) (23) (24) and Fabs were purified by affinity chromatography from the supernatant using a Strep Tactin   173 Superflow column followed by size exclusion chromatography using a Superdex 200 column.
174
Purified monomeric Fab was concentrated to approximately 25 mg/ml.
175
Complex formation, crystallization, data collection, structure determination and refinement.
176
A synthetic peptide comprising residues 406-425 (PGAKQNIQLINTNGSWHINST) of the H77 177 strain was synthetized by GenScript (> 98% purity) and dissolved in water at 10 mg/ml. Fab- 196 Model building was performed using Coot (11) and refinement was done using AutoBuster (3). We expanded on these results using alanine-scanning mutagenesis of aa 384-446 on E2, which 238 included the entire HVR1 region (aa 384 to 410) (Fig. 1C) antagonistic, additive or synergistic using the median-effect analysis method, as described in (Fig. 3A) ; fractional effect (FA) values were plotted 300 in relation to dose (Fig. 3B) 
